Cargando…

Adherence and virologic outcomes among treatment-naïve veteran patients with human immunodeficiency virus type 1 infection

Many studies have estimated the association between the adherence to antiretroviral therapies and human immunodeficiency virus (HIV) patients’ virologic/immunologic outcomes. However, evidence is lacking on the causal effect of adherence on the outcomes. The goal of this study is to understand wheth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Yan, Sauer, Brian, Zhang, Yue, Nickman, Nancy A., Jamjian, Christine, Stevens, Vanessa, LaFleur, Joanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5943894/ https://www.ncbi.nlm.nih.gov/pubmed/29480831 http://dx.doi.org/10.1097/MD.0000000000009430

Ejemplares similares

Predicting poor adherence to antiretroviral therapy among treatment-naïve veterans infected with human immunodeficiency virus
por: Cheng, Yan, et al.
Publicado: (2018)

549. Weight and BMI Changes in HIV-Infected Virologically Suppressed Adults after Switching to an Elvitegravir- or Dolutegravir-Containing Regimen
por: Gibson, Amanda, et al.
Publicado: (2018)

Cardiovascular outcomes among HIV-infected veterans receiving atazanavir
por: LaFleur, Joanne, et al.
Publicado: (2017)

Correlates of Initiation of Treatment for Chronic Hepatitis C Infection in United States Veterans, 2004–2009
por: Gundlapalli, Adi V., et al.
Publicado: (2015)

Beyond Undetectable: Modeling the Clinical Benefit of Improved Antiretroviral Adherence in Persons With Human Immunodeficiency Virus With Virologic Suppression
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2023)

Evaluating the Relationship Between Diabetes Treatment and Health Care Costs - Measuring the Atom With a Yardstick?
por: LaFleur, Joanne
Publicado: (2005)

High rates of early treatment discontinuation in hepatitis C-infected US veterans
por: LaFleur, Joanne, et al.
Publicado: (2014)

Health Care Costs in a Cohort of HIV-Infected U.S. Veterans Receiving Regimens Containing Tenofovir Disoproxil Fumarate/Emtricitabine
por: Nelson, Richard E., et al.
Publicado: (2018)

Urinary Tract Infections in Male Veterans With Human Immunodeficiency Virus
por: Eccles-Radtke, Caitlin, et al.
Publicado: (2014)

Tenofovir-Associated Bone Adverse Outcomes among a US National Historical Cohort of HIV-Infected Veterans: Risk Modification by Concomitant Antiretrovirals
por: LaFleur, Joanne, et al.
Publicado: (2018)

Cryptococcal Antigenemia in Human Immunodeficiency Virus Antiretroviral Therapy–Experienced Ugandans With Virologic Failure
por: Mpoza, Edward, et al.
Publicado: (2019)

Switching to Bictegravir, Emtricitabine, and Tenofovir Alafenamide in Virologically Suppressed Adults With Human Immunodeficiency Virus
por: Sax, Paul E, et al.
Publicado: (2020)

Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina
por: Owlia, Mina, et al.
Publicado: (2019)

Understanding the Risk of Human Immunodeficiency Virus (HIV) Virologic Failure in the Era of Undetectable Equals Untransmittable
por: Gunn, Jayleen K. L., et al.
Publicado: (2021)

Massive Release of CD9(+) Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control
por: Poveda, Eva, et al.
Publicado: (2020)

Biotypes of Central Nervous System Complications in People With Human Immunodeficiency Virus: Virology, Immunology, and Neuropathology
por: Joseph, Sarah B, et al.
Publicado: (2023)

Predictors of Mortality among United States Veterans with Human Immunodeficiency Virus and Hepatitis C Virus Coinfection
por: Erqou, Sebhat, et al.
Publicado: (2014)

Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?
por: Orrell, Catherine, et al.
Publicado: (2017)

Immuno-virological response and clinical outcome in naive elderly patients treated with antiretroviral therapy (HAART)
por: Bisicchia, F, et al.
Publicado: (2010)

PA01.69. Immunological and virological effect of amrita tablate in human immunodeficiency virus positive patients
por: Mishra, Brajeshwar
Publicado: (2012)

Unsatisfactory long-term virological suppression in human immunodeficiency virus-infected children in the Amazonas State, Brazil
por: Pacheco, Ana Luisa Opromolla, et al.
Publicado: (2020)

The Effect of Hepatitis C Virologic Clearance on Cardiovascular Disease Biomarkers in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection
por: Chew, Kara W., et al.
Publicado: (2014)

The Effect of Rosuvastatin on Markers of Immune Activation in Treatment-Naive Human Immunodeficiency Virus-Patients
por: Weijma, Robyn G. M., et al.
Publicado: (2015)

Cost minimization analysis of different growth hormone pen devices based on time-and-motion simulations
por: Nickman, Nancy A, et al.
Publicado: (2010)

Adherence to antiretrovirals in people coinfected with the human immunodeficiency virus and tuberculosis
por: Lemos, Larissa de Araújo, et al.
Publicado: (2016)

Veteran adherence to oral versus injectable AUD medication treatment
por: Stewart, Hayden, et al.
Publicado: (2021)

Advantages of switching to elvitegravir/cobicistat/emtricitabine/tenofovir therapy in virologically-suppressed people living with human immunodeficiency virus/acquired immune deficiency syndrome
por: Fan, Lina, et al.
Publicado: (2022)

Immunological factors associated with discordant virological response postcombination antiretroviral therapy in pediatric human immunodeficiency virus infection
por: Singh, Ravinder, et al.
Publicado: (2022)

Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana
por: Phinius, Bonolo Bonita, et al.
Publicado: (2020)

Plasma Profiles of Inflammatory Markers Associated With Active Tuberculosis in Antiretroviral Therapy-Naive Human Immunodeficiency Virus-Positive Individuals
por: Olsson, Oskar, et al.
Publicado: (2019)

Persistence of Human Immunodeficiency Virus-1 Drug Resistance Mutations in Proviral Deoxyribonucleic Acid After Virologic Failure of Efavirenz-Containing Antiretroviral Regimens
por: De La Cruz, Justin, et al.
Publicado: (2019)

Long-Term Virological Treatment Outcomes in Adolescents and Young Adults With Perinatally and Non-Perinatally Acquired Human Immunodeficiency Virus
por: Weijsenfeld, Annouschka M, et al.
Publicado: (2022)

Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2016)

Naive T cells are dispensable for memory CD4(+) T cell homeostasis in progressive simian immunodeficiency virus infection
por: Okoye, Afam A., et al.
Publicado: (2012)

Cost-Effectiveness of the Third-Agent Class in Treatment-Naive Human Immunodeficiency Virus-Infected Patients in Portugal
por: Aragão, Filipa, et al.
Publicado: (2012)

A study of antiretroviral resistance patterns in treatment experienced and naive human immunodeficiency virus infected-patients
por: Harjani, Raj, et al.
Publicado: (2016)

Sustained Virologic Suppression After 4 Weeks of Ledipasvir/Sofosbuvir in Human Immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) Co-Infection
por: Havens, Joshua P., et al.
Publicado: (2020)

The Virology of Taterapox Virus In Vitro
por: Parker, Scott, et al.
Publicado: (2018)

Virology of hepatitis C virus
por: Simmonds, Peter
Publicado: (1996)

The Molecular Virology of Enteric Viruses
por: Buesa, Javier, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qgokbccbcdehf6e53lqs9t316b